Functional analysis of CTLA4 promoter variant and its possible implication in colorectal cancer immunotherapy
BackgroundColorectal cancer (CRC) is a prevalent cancer, ranking as the third most common. Recent advances in our understanding of the molecular causes of this disease have highlighted the crucial role of tumor immune evasion in its initiation and progression. CTLA4, a receptor that acts as a negati...
Main Authors: | Mariana Angulo-Aguado, Sarah Orjuela-Amarillo, Julián Francisco Mora-Jácome, Lea Paloma Córdoba, Antonio Gallego-Ortiz, Cristian Camilo Gaviria-Sabogal, Nora Contreras, Carlos Figueroa, Oscar Ortega-Recalde, Adrien Morel, Dora Janeth Fonseca-Mendoza |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-08-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2023.1160368/full |
Similar Items
-
Impact of CTLA-4 checkpoint antibodies on ligand binding and Transendocytosis
by: Cayman Williams, et al.
Published: (2022-08-01) -
Adverse Events Following Administration of Anti-CTLA4 Antibody Ipilimumab
by: Amirali Karimi, et al.
Published: (2021-03-01) -
CTLA4 DNA methylation is associated with CTLA-4 expression and predicts response to immunotherapy in head and neck squamous cell carcinoma
by: Friederike Hoffmann, et al.
Published: (2023-07-01) -
Preponderance of CTLA4 Variation Associated With Autosomal Dominant Immune Dysregulation in the MYPPPY Motif
by: Owen M. Siggs, et al.
Published: (2019-07-01) -
CTLA-4 CT-60 A/G and CTLA-4 1822 C/T Gene Polymorphisms in Indonesians with Type 1 Diabetes Mellitus
by: Rochmah N, et al.
Published: (2022-04-01)